Soliman, B., Ali, M., Toraih, E., Ahmed, M. (2018). Mitochondrial Translocase Expression Profile in Renal Cancer. The Egyptian Journal of Hospital Medicine, 70(6), 974-979. doi: 10.12816/0044346
Belal Ahmed Soliman; Mohamed Hassany Ali; Eman Ali Toraih; Mohamed Abdelhamid Hasan Ahmed. "Mitochondrial Translocase Expression Profile in Renal Cancer". The Egyptian Journal of Hospital Medicine, 70, 6, 2018, 974-979. doi: 10.12816/0044346
Soliman, B., Ali, M., Toraih, E., Ahmed, M. (2018). 'Mitochondrial Translocase Expression Profile in Renal Cancer', The Egyptian Journal of Hospital Medicine, 70(6), pp. 974-979. doi: 10.12816/0044346
Soliman, B., Ali, M., Toraih, E., Ahmed, M. Mitochondrial Translocase Expression Profile in Renal Cancer. The Egyptian Journal of Hospital Medicine, 2018; 70(6): 974-979. doi: 10.12816/0044346
Mitochondrial Translocase Expression Profile in Renal Cancer
1Department of Zoology, Faculty of Science, Suez Canal University
22 Department of Histology and Genetics, Faculty of Medicine, Suez Canal University
3Department of Pathology, Faculty of Medicine, Suez Canal University
Abstract
Background: mitochondrial appropriate function depends on ideal mitochondrial translocation machinery, of which translocase of outer mitochondrial membrane (TOMM) have a vital role in normal functioning cell. Any disturbance in the translocation machinery leads to either tumorigenesis or apoptosis. Aim of the work: This study aimed to investigate the expression of TOMM34 in renal cell carcinoma (RCC). TOMM34 expression was assessed in 42 samples of RCC patients using immunohistochemistry technique. Results: immunohistochemical staining revealed significant accumulation of TOMM34 protein in RCC cases compared to their corresponding non-cancerous renal tissues. TOMM34 protein expression was significantly associated with age and gender categories in contrast to the other clinicopathological features. Conclusion: according to protein expression level this study demonstrated that TOMM34 is a marker of poor outcome in RCC.